Ligand validation:7L2C

NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose

NAG is a Ligand Of Interest in 7L2C designated by the Author

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
7L2C_NAG_A_407	31%	30%	0.202	0.873	1.16	1.64	1	3	0	0	100%	0.9333
7L2C_NAG_A_404	26%	84%	0.224	0.866	0.19	0.57	-	-	0	0	100%	0.9333
7L2C_NAG_A_402	17%	75%	0.231	0.811	0.36	0.6	-	1	0	0	100%	0.9333
7L2C_NAG_A_403	17%	21%	0.281	0.86	0.91	2.36	1	2	0	0	100%	0.9333
7L2C_NAG_B_403	14%	81%	0.238	0.792	0.25	0.56	-	-	0	0	100%	0.9333
7L2C_NAG_B_406	12%	52%	0.297	0.827	0.55	1.27	-	1	0	0	100%	0.9333
7L2C_NAG_B_402	8%	75%	0.284	0.767	0.53	0.46	-	-	0	0	100%	0.9333
7L2C_NAG_B_401	8%	88%	0.301	0.777	0.28	0.38	-	-	0	0	100%	0.9333
7L2C_NAG_A_401	7%	75%	0.317	0.774	0.43	0.56	-	-	0	0	100%	0.9333
7L2C_NAG_B_404	5%	47%	0.296	0.693	0.45	1.55	-	2	0	0	100%	0.9333
7L2C_NAG_A_405	5%	40%	0.383	0.781	0.99	1.34	1	3	0	0	100%	0.9333
7L2C_NAG_A_406	4%	56%	0.326	0.686	0.43	1.24	-	2	0	0	100%	0.9333
7L2C_NAG_B_405	0%	51%	0.537	0.561	0.56	1.3	-	2	0	0	100%	0.9333
7B62_NAG_A_1304	94%	75%	0.08	0.978	0.35	0.61	-	-	0	0	100%	0.9333
5LDS_NAG_B_1007	100%	67%	0.022	0.995	0.48	0.79	-	-	0	0	100%	0.9333
5O5D_NAG_A_601	100%	65%	0.022	0.994	0.32	0.99	-	1	0	0	100%	0.9333
6MUG_NAG_G_629	100%	76%	0.022	0.994	0.35	0.58	-	-	0	0	100%	0.9333
3PPS_NAG_B_760	100%	44%	0.028	0.993	0.57	1.57	-	3	0	0	100%	0.9333
5O59_NAG_A_601	100%	70%	0.024	0.993	0.3	0.85	-	-	0	0	100%	0.9333

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.